These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32524083)

  • 1. 2018 Position Paper on Biosimilars of the Greek Rheumatology Society and Professional Association of Greek Rheumatologists.
    Patrikos D; Boki K; Boumpas D; Vassilopoulos D
    Mediterr J Rheumatol; 2019 Jun; 30(Suppl 1):82-83. PubMed ID: 32524083
    [No Abstract]   [Full Text] [Related]  

  • 2. The Portuguese Society of Rheumatology position paper on the use of biosimilars - 2017 update.
    Araújo FC; Sepriano A; Teixeira F; Jesus D; Rocha TM; Martins P; Tenazinha C; Cordeiro A; Mourão AF; Silva C; Vaz C; Duarte C; Ponte C; Dos Santos FP; Canhão H; Santos H; Pimentão JB; da Silva JC; Pereira J; da Silva JAP; Miranda LC; Oliveira M; Saavedra MJ; Gonçalves P; Falcão S; Capela S; Fonseca JE
    Acta Reumatol Port; 2017; 42(3):219-228. PubMed ID: 28894080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Greek (Hellenic) rheumatology over the years: from ancient to modern times.
    Sakkas LI; Tronzas P
    Rheumatol Int; 2019 Jun; 39(6):947-955. PubMed ID: 30805680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosimilars: complements and comments on the recent statement of the SFR and CRI. Comment on: "Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI)." Schaeverbeke et al. Joint Bone Spine 2018;95:399-402.
    Cohen JD; Tropé S; Munos A; Bocquet F
    Joint Bone Spine; 2019 Mar; 86(2):287-288. PubMed ID: 30394338
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany.
    Waller J; Sullivan E; Piercy J; Black CM; Kachroo S
    Patient Prefer Adherence; 2017; 11():519-530. PubMed ID: 28331299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatology training and research in Iran.
    Khabbazi A; Soroosh M
    Rheumatol Int; 2019 Aug; 39(8):1307-1319. PubMed ID: 31111293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Portuguese Society of Rheumatology position paper on the use of biosimilars.
    Fonseca JE; Gonçalves J; Araújo F; Cordeiro I; Teixeira F; Canhão H; da Silva JA; Garcês S; Miranda LC; Ramiro S; Roxo A; Pimentel-Santos FM; Tavares V; Neto A; Sepriano A; Malcata A; Faustino A; Silva C; Ambrósio C; Duarte C; Miguel C; Barcelos F; Santos H; Cunha I; Ramos JC; Gomes JA; Pimentão JB; Costa L; Maurício L; Silva M; Bernardes M; Bogas M; Coelho PC; Monteiro P; Aguiar R; André R; Leitão R; Pimenta S; Meirinhos T; Fernandes S; Las V; Castelão W;
    Acta Reumatol Port; 2014; 39(1):60-71. PubMed ID: 24811463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of new biosimilars in rheumatology and gastroenterology specialities on UK healthcare budgets: Results of a budget impact analysis.
    Aladul MI; Fitzpatrick RW; Chapman SR
    Res Social Adm Pharm; 2019 Mar; 15(3):310-317. PubMed ID: 29807834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Position paper from the Spanish Society of Rheumatology on biosimilar drugs.
    Abad Hernández MÁ; Andreu JL; Caracuel Ruiz MÁ; Belmonte Serrano MÁ; Díaz-González F; Moreno Muelas JV
    Reumatol Clin; 2015; 11(5):269-78. PubMed ID: 25982595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey on management strategies of rheumatoid arthritis in Saudi Arabia: a Saudi Society for Rheumatology Initiative.
    Omair MA; Omair MA; Halabi H
    Int J Rheum Dis; 2017 Sep; 20(9):1185-1192. PubMed ID: 26354409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists.
    van Overbeeke E; De Beleyr B; de Hoon J; Westhovens R; Huys I
    BioDrugs; 2017 Oct; 31(5):447-459. PubMed ID: 28929342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing landscape of biosimilars in rheumatology.
    Dörner T; Strand V; Cornes P; Gonçalves J; Gulácsi L; Kay J; Kvien TK; Smolen J; Tanaka Y; Burmester GR
    Ann Rheum Dis; 2016 Jun; 75(6):974-82. PubMed ID: 26964144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Memorandum of the German Society for Rheumatology on the quality of treatment in rheumatology - Update 2016].
    Zink A; Braun J; Gromnica-Ihle E; Krause D; Lakomek HJ; Mau W; Müller-Ladner U; Rautenstrauch J; Specker C; Schneider M
    Z Rheumatol; 2017 Apr; 76(3):195-207. PubMed ID: 28364218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper.
    Fiorino G; Girolomoni G; Lapadula G; Orlando A; Danese S; Olivieri I;
    Autoimmun Rev; 2014 Jul; 13(7):751-5. PubMed ID: 24657898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opinion of some Brazilian rheumatologists about biosimilars.
    Azevedo VF; Felippe LR; Machado DM
    Rev Bras Reumatol; 2011 Dec; 51(6):667-71. PubMed ID: 22124600
    [No Abstract]   [Full Text] [Related]  

  • 16. The Supply of Rheumatology Specialist Care in Real Life. Results of a Nationwide Survey and Analysis of Supply and Needs.
    Puchner R; Vavrovsky A; Pieringer H; Hochreiter R; Machold KP
    Front Med (Lausanne); 2020; 7():16. PubMed ID: 32083088
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on: The Portuguese Society of Rheumatology position paper on the use of biosimilars.
    Müller-Ladner U
    Acta Reumatol Port; 2014; 39(1):7-8. PubMed ID: 24811455
    [No Abstract]   [Full Text] [Related]  

  • 18. Review of Current Workforce for Rheumatology in the Countries of the Americas 2012-2015.
    Reveille JD; Muñoz R; Soriano E; Albanese M; Espada G; Lozada CJ; Montúfar RA; Neubarth F; Vasquez GM; Zummer M; Sheen R; Caballero-Uribe CV; Pineda C
    J Clin Rheumatol; 2016 Dec; 22(8):405-410. PubMed ID: 27870762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Korean rheumatology workforce from 1992 to 2015: current status and future demand.
    Lee CU; Kim JN; Kim JW; Park SH; Lee H; Kim SK; Choe JY
    Korean J Intern Med; 2019 May; 34(3):660-668. PubMed ID: 29232941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survey of rheumatologists in Saxony, Saxony-Anhalt and Thuringia regarding the occupational situation and activities in further education: no way out of the undersupply of rheumatological care].
    Keyßer G; Baerwald CGO; Sieburg M; Boche K; Pfeil A; Kupka TA; Lüthke K; Heldmann F; Oelzner P; Unger L; Aringer M
    Z Rheumatol; 2019 Jun; 78(5):479-485. PubMed ID: 31087134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.